Dr. Reddy's Laboratories has entered into an exclusive partnership with Sanofi Healthcare India (SHIPL) to promote and distribute their vaccine brands across private markets in India. Under the arrangement, Dr. Reddy’s will have exclusive rights to promote and distribute Sanofi’s well established and trusted paediatric and adult vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U. These brands saw combined sales of around Rs 426 crore as per IQVIA MAT February 2024. Sanofi will continue to own, manufacture, and import these brands to the country.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
